ANTIOXIDANT VITAMINS (A, C AND E) AND MALONDIALDEHYDE LEVELS IN ACUTE EXACERBATION AND STABLE PERIODS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Main Article Content
Keywords
COPD, Malondialdehyde, Vitamins A, C, and E, Stable periods, Antioxidant
Abstract
Background: During exacerbations, those with stable episodes of persistent obstructive pulmonary disease (COPD) sustain oxidative damage, which gradually advances the illness's pathogenesis. Since the blood level of these nutrients in patients with COPD have not been thoroughly studied, we examined the levels of antioxidant vitamins and lipid peroxidation in individuals during acute flare-ups and stable periods.
Objective: Determining the amounts of malondialdehyde and antioxidant vitamins A, C, and E in individuals with chronic obstructive pulmonary disease during periods of acute exacerbation and stability was the goal.
Study Design: Prospective study
Place and Duration: Ayub Medical College, Abbottabad, from Jan 2022 to Jan 2023.
Methods: 56 COPD patients in all are experiencing an acute exacerbation. Using high-performance liquid chromatography and known techniques, the serum concentrations of malondialdehyde (MDA) and vitamins A, C, and E were measured before to therapy, during stable periods, and in 28 healthy controls. Every data was analysed using SPSS 23.0.
Results: Compared to the healthy group, the COPD group had considerably reduced plasma levels of vitamins A, E and C, as well as α- and βcarotenes and total carotenoids. There was a strong correlation between endogenous DNA damage to WBCs and plasma levels of vitamin E. Less significantly (0.05< p <0.10), we also discovered negative correlations between endogenous DNA damage and plasma levels of lutein or α-carotene. The total consumption of fruits and vegetables (OR=0.91; 95% CI=0.94-0.95) alone reduced the risk of COPD, Age and smoking history, both previous and current, separately increased the likelihood of COPD. These findings were obtained via the logistic regression analysis. On the other hand, the risk of COPD was not influenced by the consumption of particular nutrients.
Conclusion: During periods of stability, the concentration of antioxidant vitamins A and E in the blood decreases during exacerbations, and patients with COPD experience greater oxidative stress during these episodes. The results of our research indicate that vitamin A and E supplementation may be helpful in preventing and treating the negative consequences of COPD.
References
1. 2.GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, “Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017,” Lancet, vol. 392, no. 10159, pp. 1789–1858, 2018.
2. 3.GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, “Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017,” Lancet, vol. 392, no. 10159, pp. 1736–1788, 2018.
3. Cavaillès, A.; Brinchault-Rabin, G.; Dixmier, A.; Goupil, F.; Gut-Gobert, C.; Marchand-Adam, S.; Meurice, J.-C.; Morel, H.; Person-Tacnet, C.; Leroyer, C.; et al. Comorbidities of COPD. Eur. Respir. Rev. 2013, 22, 454–475.
4. Brassington, K.; Selemidis, S.; Bozinovski, S.; Vlahos, R. Chronic obstructive pulmonary disease and atherosclerosis: Common mechanisms and novel therapeutics. Clin. Sci. 2022, 136, 405–423.
5. Austin, V.; Crack, P.; Bozinovski, S.; Miller, A.A.; Vlahos, R. COPD and stroke: Are systemic inflammation and oxidative stress the missing links? Clin. Sci. 2016, 130, 1039–1050.
6. Agacdiken A, Basyigit I, Ozden M, Yildiz F, Ural D, Maral H, Boyaci H, Ilgazli A, Komsuoglu B: The effects of antioxidants on exercise-induced lipid peroxidation in patients with COPD. Respirology 2004,9(1):38–42.
7. Allen S, Britton JR, Leonardi-Bee JA: Association between antioxidant vitamins and asthma outcome measures: systematic review and meta-analysis. Thorax 2009,64(7):610–9.
8. Smit HA: Chronic obstructive pulmonary disease, asthma and protective effects of food intake: from hypothesis to evidence? Respir Res 2001,2(5):261–4.
9. Tug T, Karatas F, Terzi SM: Antioxidant vitamins (A, C and E) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary disease. Clin Invest Med 2004,27(3):123–8.
10. Barnes PJ. Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc 2008; 5 (8): 857-864
11. S. Khan, A. Javaid, R. A. Ghori, K. Mahmood, N. Anwer, S. U. Khan, et al. Cefaclor AF vs Clarithromycin in Acute Exacerbation of Chronic Bronchitis. J Pak Med Assoc 2003; 53 (8): 338-345.
12. Deslee G, Woods JC, Moore C, Conradi SH, Gierada DS, Atkinson JJ, et al. Oxidative damage to nucleic acids in severe emphysema. Chest. 2009;135:965-74.
13. McKeever TM, Lewis SA, Smit HA, Burney P, Cassano PA, Britton J. A multivariate analysis of serum nutrient levels and lung function. Respir Res. 2008;9:67.
14. Ceylan E, Kocyigit A, Gencer M, Aksoy N, Selek S. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass. Respir Med. 2006;100:1270-6.
15. Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Browne RW, et al. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD. Eur J Clin Nutr. 2006;60:991-9.
16. P. A. Kirkham and P. J. Barnes, “Oxidative stress in COPD,” Chest, vol. 144, no. 1, pp. 266–273, 2013.
17. B.Fischer, J. Voynow, and A. Ghio, “COPD: balancing oxidants and antioxidants,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 10, pp. 261–276, 2015.
18. Watson L, Margetts B, Howarth P, Dorward M, Thompson R, Little P. The association between diet and chronic obstructive pulmonary disease in subjects selected from general practice. Eur Respir J. 2002;20:313-8.
19. Garcia-Lafuente A, Guillamon E, Villares A, Rostagno MA, Martinez JA. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res. 2009;58:537-52.
20. Tabak C, Arts IC, Smit HA, Heederik D, Kromhout D. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN Study. Am J Respir Crit Care Med. 2001;164:61-4.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Sofia Shoukat
Assistant Professor, Department of Biochemistry, Ayub Medical College, Abbottabad
Dr Sajjad Khan
Specialist Internal Medicine, LLH Hospital, Musaffah, Abu Dhabi UAE
Dr Maria Sarfraz
Associate Professor, Department of Biochemistry, Rawal Institute of Health Sciences, Islamabad Pakistan
Dr Maheen Saad
Assistant Professor, MBBS, MPhil, CHPE, Department of Biochemistry, Fazaia Medical College, Islamabad Pakistan
Dr Lubna Siddique
Associate Professor, Department of Physiology, Rawal Institute of Health Sciences, Islamabad Pakistan
Dr Sajid Khan
Department of Biochemistry, Jinnah Medical College, Peshawar Pakistan